Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Active, not recruiting Observational

The USE of ULTRASONOGRAPHY in CONFIRMING SUPRAGLOTTIC AIRWAY DEVICE PLACEMENT in PEDIATRIC PATIENTS

NCT06664294 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2024-07-29
Last updated
2024-10-29

Condition(s) studied

Airway Ultrasound

Study summary

In this study,the investigators evaluated the placement of the supraglottic airway device with ultrasonographic imaging.

Eligibility

Sex
ALL
Min age
3 Years
Max age
15 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Patients with informed consent from their parents * Patients with ASA I-II physical status * Patients with appropriate fasting time * Those with an operation time of less than 2 hours Exclusion Criteria: * ASA III-IV physical status patients * Patients with respiratory tract infections * Patients undergoing head and neck surgery * Patients with oropharyngeal pathology * Patients with gastrointestinal obstruction * Patients with tracheomalacia * Patients who need to be intubated for anesthesia applications

Primary outcome measure(s)

  • correlation between ultrasonography and clinical tests — 24 hours
    Our primary aim was investigation of correlation between ultrasonography and clinical tests for placement of supraglottic airway device in pediatric patients.

Trial sites (1)

FacilityCityRegionStatus
Kocaeli University İzmit Kocaeli
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06664294 on ClinicalTrials.gov ↗ ← All trials in Turkey